Studies in the triple‐transgenic mouse AD model showed NQO1 upregulation in the hippocampus and cortex in early stages of the disease, followed by a gradual decrease in expression (Torres‐Lista et al., 2014). Here, NQO1 is linked to Alzheimer disease.